Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc. is a clinical stage biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction leading to anti-cancer immune activation. Our new approach involves the direct injection into tumors of a unique product created from our DfuseRx℠ discovery platform.Our lead product candidate, INT230-6, consists of two proven anti-cancer cytotoxic agents, cisplatin […]
December 2, 2021 Read More